Atesidorsen

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAtesidorsen
Drug Alias NameCOR-004ATL-1103
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGrowth hormone receptor antagonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAntisense TherapeuticsIonis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAcromegaly
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A